The market for metabolic diseases has seen a tumultuous few years. Our experts will help you to understand how competitors are adjusting their pipeline and commercial activity in an increasingly crowded sector, and how they are responding to ongoing changes in regulation and reimbursement as the commercial prospects of the market change.
Once you’ve registered you’ll have access to in-depth analysis of chronic kidney disease, dyslipidemia, diabetes type 1 and type 2, obesity and osteoporosis therapies for the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK).
To get started…
As pharma continues to grow and evolve, our expert company analysis will help you to assess and compare industry players in terms of sales growth, therapeutic focus, launch/expiry balance, diversification, and profitability.
Use the PharmaVitae Explorer 2.0 to compare companies and take full advantage of our new and expanded coverage of the lucrative biosimilars space.
The Datamonitor Healthcare Client Services team know their way around your service better than anyone. They offer practical tips on how to make the most of your analysis and will always be on hand to offer direction, advice and support.
Take this opportunity to join one of our introductory training sessions where you’ll learn about the latest research enhancements, interactive dashboards and automated alerts.
Datamonitor Healthcare-Pfizer Training:
|Tuesday, 12 January 2016||Thursday, 14 January 2016|
|10:00 GMT | 30 mins||9:00 GMT | 30 mins|
|16:00 GMT | 11:00 EST | 30 mins||15:00 | 10:00 EST | 30 mins|
Client Support and Training
Tel (EU): +44 20 7551 9201
Tel (US): +1 212 520 2726
Tel (AP): +61 2 8705 690
You now have full access to all articles on our site for the next 28 days.